Document ID: chunk:federal_register_of_legislation:F2024C01114:clause:7_29:p3
Version: federal_register_of_legislation:F2024C01114
Segment Type: clause
Provision Reference: sch 7 cl 29 (pt 3/7)
Character Range: 44709–47563

of the Act, this rule applies to an insurance policy that covers hospital treatment (whether or not the policy also covers general treatment).
 (2) The policy must include a name that contains the policy's product tier.
 (3) If the policy covers one or more clinical categories additional to those required for a policy of that product tier in Schedule 4, the name may also contain "plus" or "+".
 (4) The name must not contain:
 (a) the name of any other metal; or
 (b) the name of any gemstone or any semi‑precious stone; or
 (c) unless permitted by subrule (3)—either "plus" or "+".

11J. Naming of insurance policies that cover general treatment only
 (1) For paragraph 63‑10 (g) of the Act, this rule applies to an insurance policy that covers general treatment only.
 (2) The policy must include a name that does not contain:
 (a) the name of any metal; or
 (b) the name of any gemstone or any semi‑precious stone; or
 (c) either "plus" or "+".

Part 3 Private health information statements and other information that must be given

           Note: This Part deals with:

            the information and form for private health information statements, for the purposes of subsection 93‑5 (1) of the Act, and methods by which private health information statements are made available; and

            information that must be provided to the Private Health Insurance Ombudsman relating to changes in premiums.

            This Part does not limit the information that a private health insurer may give to an insured person.

     12.  Private health information statements

           Note: See rule 20 for a transitional provision relating to this rule that applies until 31 March 2020.

      (1) For subsection 93‑5 (1) of the Act, the information to be contained in a private health information statement, and the form, for a product subgroup of a complying health insurance product, are:
           (a) the information and form of words set out in Schedule 1; and
           (b) if policies that belong to the product subgroup cover hospital treatment—the additional information, and the form of words, set out in Schedule 2; and
           (c) if policies that belong to the product subgroup cover general treatment—the additional information, and the form of words, set out in Schedule 3.

      (2) However, paragraph (1)(c) does not apply if the only general treatment provided is ambulance cover.

     13.  Method of making private health information statements available

      (1) This rule is made for the purposes of subsection 93‑5 (2) and paragraph 93‑15 (1) (a) of the Act.

      (2) If:
           (a) the private health information statement is accompanied by information additional to the information and form of words that are required by subrule 12 (1); and
           (b) the private health information statement and the